10x Genomics Snags $55M In Funding To Help Commercialize Its DNA Sequencing Technologies
The company's CEO says its technology -- which can sit atop other equipment -- bridges gaps to provide more context about the DNA.
The San Francisco Business Times:
With Another $55M, East Bay Company Brings Clarity To DNA Sequencing
A fast-moving Pleasanton company landed $55 million in Series C financing, it said Thursday, to help commercialize its DNA sequencing technologies and push more through the pipeline. 10x Genomics Inc. said the funding was led by Fidelity Management & Research Co. and included new investors Softbank and JS Capital Management LLC, the private investment firm overseen by Jonathan Soros, the son of billionaire and political financier George Soros. (Leuty, 3/17)
Meanwhile, Spirox, a California-based company that specializes in making medical devices for patients with blocked noses, gets a $45 million investment —
Reuters:
KKR Leads $45M Investment In Medical Maker
Private equity firm KKR & Co LP (KKR.N) said on Tuesday it is investing $45 million into California-based medical device maker Spirox Inc with a group of other investors, the latest in a string of similar deals in the sector. KKR led the latest round of financing that included investors such as venture capital fund HealthQuest Capital, private equity firm Aisling Capital and investment firm Aperture Venture Partners. (3/15)